Genor Biopharma Holdings Limited (6998.HK)

HKD 1.66

(-5.68%)

Operating Income Summary of Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited's latest annual operating income in 2023 was -711.19 Million CNY , up 9.54% from previous year.
Genor Biopharma Holdings Limited's latest quarterly operating income in 2024 Q2 was -65.03 Million CNY , down 0.0% from previous quarter.
Genor Biopharma Holdings Limited reported an annual operating income of -786.2 Million CNY in 2022, up 8.49% from previous year.
Genor Biopharma Holdings Limited reported an annual operating income of -859.1 Million CNY in 2021, up 7.07% from previous year.
Genor Biopharma Holdings Limited reported a quarterly operating income of -65.03 Million CNY for 2024 Q1, up 68.69% from previous quarter.
Genor Biopharma Holdings Limited reported a quarterly operating income of -143.47 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Genor Biopharma Holdings Limited (2023 - 2018)

Historical Annual Operating Income of Genor Biopharma Holdings Limited (2023 - 2018)

Year	Operating Income	Operating Income Growth
2023	-711.19 Million CNY	9.54%
2022	-786.2 Million CNY	8.49%
2021	-859.1 Million CNY	7.07%
2020	-924.42 Million CNY	-79.51%
2019	-514.97 Million CNY	-83.79%
2018	-280.18 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-65.03 Million CNY	0.0%
2024 Q1	-65.03 Million CNY	68.69%
2023 Q2	-143.47 Million CNY	0.0%
2023 Q4	-207.7 Million CNY	-26.13%
2023 Q3	-164.67 Million CNY	-14.78%
2023 FY	-616.29 Million CNY	21.61%
2023 Q1	-143.47 Million CNY	17.95%
2022 Q3	-174.85 Million CNY	19.7%
2022 Q2	-217.74 Million CNY	0.0%
2022 Q1	-217.74 Million CNY	11.12%
2022 FY	-786.2 Million CNY	8.49%
2022 Q4	-174.85 Million CNY	0.0%
2021 Q1	-197.1 Million CNY	8.32%
2021 FY	-859.1 Million CNY	7.07%
2021 Q4	-244.99 Million CNY	0.0%
2021 Q3	-244.99 Million CNY	-24.3%
2021 Q2	-197.1 Million CNY	0.0%
2020 Q1	-142.78 Million CNY	0.0%
2020 Q4	-214.98 Million CNY	0.0%
2020 Q3	-214.98 Million CNY	44.31%
2020 Q2	-386.04 Million CNY	-170.37%
2020 FY	-924.42 Million CNY	-79.51%
2019 FY	-514.97 Million CNY	-83.79%
2019 Q1	-74.14 Million CNY	0.0%
2018 FY	-280.18 Million CNY	0.0%

Peer Operating Income Comparison of Genor Biopharma Holdings Limited

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	1149.457%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	179.202%